Ikapharmindo Putramas Tbk PT
IDX:IKPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.7), the stock would be worth Rp224 (11% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.6 | Rp202 |
0%
|
| 3-Year Average | 1.7 | Rp224 |
+11%
|
| 5-Year Average | 1.7 | Rp224 |
+11%
|
| Industry Average | 27.6 | Rp3 585.93 |
+1 675%
|
| Country Average | 1.6 | Rp208.09 |
+3%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| ID |
I
|
Ikapharmindo Putramas Tbk PT
IDX:IKPM
|
340.3B IDR | 1.6 | -11.8 | |
| US |
|
Kenvue Inc
NYSE:KVUE
|
33.6B USD | 3.1 | 22.9 | |
| KR |
A
|
APR Co Ltd
KRX:278470
|
17.2T KRW | 38.7 | 59.6 | |
| BR |
|
Natura &Co Holding SA
OTC:NTCOY
|
7.7B USD | 2.6 | -4.4 | |
| KY |
H
|
Herbalife Ltd
XMUN:HOO
|
4.6B EUR | -10.4 | 23.5 | |
| CN |
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
36.1B HKD | 6.5 | 25.2 | |
| KR |
d
|
d'Alba Global Co Ltd
KRX:483650
|
2.9T KRW | 14.7 | 36.9 | |
| CN |
|
Runben Biotechnology Co Ltd
SSE:603193
|
10.8B CNY | 4.9 | 34.7 | |
| IN |
H
|
Honasa Consumer Ltd
NSE:HONASA
|
113.1B INR | 8.9 | 72.6 | |
| IL |
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
887.2m USD | 2.2 | 8 | |
| CN |
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
5.8B CNY | 3.9 | 31.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.6 |
| 70th Percentile | 2.9 |
| Max | 652 108.7 |
Other Multiples
Ikapharmindo Putramas Tbk PT
Glance View
Ikapharmindo Putramas Tbk PT is a ID-based company operating in Personal Care Products industry. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 983 full-time employees. The company went IPO on 2023-11-08. PT Ikapharmindo Putramas Tbk. is an Indonesia-based company, which is engaged in the marketing of pharmaceutical products and consumer health products located in Jakarta, Indonesia. The firm operates through two segments: Non Pharma, Pharma, and Contract manufacturing. The firm is focused on a diverse portfolio for the Indonesian market, with brands in the pharmaceutical product categories of prescription medicines, over the counter (OTC), nutraceuticals, professional hair care products and baby products. Its prescription pharmaceuticals include neurology, dermatology, gastroenterology, and cardiology. Its consumer division products consist of professional and retail haircare products, and also Baby HUKI, which consists of baby bottles and pacifiers, and other baby feeding equipment.
